Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.41 |
| ▸ | TP53 | P04637 | 7/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL742502 | 0.92 | MAPT (0.43) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL742501 | 0.92 | MAPT (0.43) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL764414 | 0.92 | MAPT (0.41) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL10292170 | 0.91 | MAPT (0.40) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL10292328 | 0.90 | KCNH2 (0.41) | MAPTTP53HRH1CYP2D6KCNH2 | |
| SCHEMBL10292169 | 0.89 | HRH1 (0.39) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL763792 | 0.89 | HRH1 (0.39) | MAPTTP53THRBHRH1CYP2D6 | |
| SCHEMBL763178 | 0.89 | HRH1 (0.43) | MAPTTP53HRH1CYP2D6KCNH2 | |
| SCHEMBL763880 | 0.89 | HRH1 (0.43) | MAPTTP53HRH1CYP2D6KCNH2 | |
| SCHEMBL763858 | 0.89 | KCNH2 (0.42) | HRH1CYP2D6KCNH2POLBCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138168-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |